Cameroon

in page functions
Total population (2012)20,468,943
Birth cohort (2012)720,879
Surviving Infants (surviving to 1 year per year, 2012)658,784
Infant mortality rate (deaths < 1 year per 1000 births, 2012)86.14/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012)137.83/1000
World Bank Index, IDA (2012)3.17
Gross Nation Income (per capita US$, 2010)1,180
Co-financing status (2012)Intermediate
No. of districts/territories (2009)173

GAVI support for Cameroon

Type of support

Approvals

2001-2016 (US$)
(31 Dec 2011)

Commitments

2001-2016 (US$)
(31 Dec 2011)

Disbursements

2001-2012 (US$)
(31 Dec 2011)

% Disbursed

(31 Dec 2011)
200120022003200420052006200720082009201020112012201320142015
Civil Society Organisation support (CSO)$56,199N/A
Health System Strengthening (HSS)$9,846,000$9,846,000$7,762,00079%
Immunisation Services Support (ISS)$7,983,620$9,381,120$6,584,12082%
Injection Safety Support (INS)$992,844$992,844$992,844100%
Meningitis A - campaign (NVS)$4,634,000$4,634,000$4,491,40897%
Operational Support$1,803,735$1,803,735$1,803,735100%
Penta (NVS)$30,897,331$49,922,831$23,200,30075%
Pneumo (NVS)$28,677,000$66,450,500$15,674,46055%
Rotavirus (NVS)0$12,401,000N/A
Tetra DTP-HepB (NVS)$9,000,675$9,000,675$9,000,675100%
Vaccine Introduction Grant$632,000$914,500$632,000100%
Yellow Fever (NVS)$5,142,135$6,229,135$5,207,269101%
Total$99,609,340$171,576,340$75,405,009

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Cameroon DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2010)84%
DTP3 - Official country estimates (2010)84%
M:F sex ratio at birth (2012)1.03%
Household survey: DTP3 coverage for male (2006)72.60%
Household survey: DTP3 coverage for female (2006)78.00%
Household survey: Last DTP3 survey (2006)75%
% districts achieving > 80% DTP3 coverage (2010)15%
% districts achieving < 50% DTP3 coverage (2010)4%
MCV WHO/UNICEF estimates (2010)79%
Polio WHO/UNICEF estimates (2010)83%

Breakdown of support

CSO, HSS & ISS supportVaccine support
24% 76%
$17,830,898 $57,574,112

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Cameroon

21 February 2012

Nigeria MenA

Q and A on Nigeria’s introduction of MenAfriVac

Interview with Muhammad Sani Adamu, Head of Accelerated Disease Control in Nigeria’s National Primary Health Care Development Agency, who played a key role in rolling out the new vaccine against meningitis A, MenAfriVac, to Nigeria’s northern states.

26 January 2012

Chad’s campaign against meningitis A

One of the first countries to introduce the new meningitis A vaccine (MenAfriVac), Chad ran an immunisation campaign with GAVI support in December 2011 to help eliminate the region’s devastating epidemics.

19 January 2012

Map showing Niger and Cameroon

GAVI works with Cameroon and Niger to recover misused funds

Following separate investigations into the misuse of GAVI funding in Cameroon and Niger, both Ministries of Health have cooperated fully and confirmed their commitment to take all necessary measures, including the reimbursement of misused funds. [Français]

close icon

modal window here